LIVE Demo of New HistofreezerĀ® FLEX Featured in Upcoming Webinar

Webinar will feature tips to help healthcare professionals get better first-time results when treating common skin lesions

LEHIGH VALLEY, PA ā€“ CryoConcepts, LP, the market leader in portable cryosurgery, announced a CryoEDU Webinar series that will focus on new developments in the world of portable cryosurgery. The first webinar will be held on October 29, 2020 at 3pm and 7pm and will demonstrate how the new HistofreezerĀ® FLEX will improve the standard of care with cryosurgery for many common skin lesions.Ā  A recording of both sessions will also be available after the live air date on the companyā€™s website atĀ www.cryoconcepts.com.

“We are excited to share the latest developments in portable cryosurgery with the goal of helping practitioners achieve better first-time results,” said Dr. Sam Niedbala, CEO of CryoConcepts, LP.Ā  “Our content will be very hands-on, and we will show specific real-world treatment protocols,” he added.

Attendees will gain a practical understanding of the principles of cryosurgery, cryosurgical productsĀ  and how to use Histofreezer FLEXā€™s new bud and cone technology to maximize results on a variety of skin lesions. The presentation will also cover Histofreezer Flexā€™s new innovative eco-friendly refillable canister design, providing healthcare providers with a responsible cryosurgery choice for outcomes, and the environment.

Participate in the First Webinar in the CryoEDU Webinar Series

CLICK HERE TO REGISTER

About CryoConcepts, LP CryoConcepts, LP, located in Bethlehem, PA, is the global market leader in portable cryosurgery.Ā  The company manufactures a complete line of cryosurgical products for the licensed healthcare professional, veterinary, and esthetics markets worldwide

CryoConcepts Receives FDA Clearance on Two Cryosurgical Devices for the Physician Office Market

Bethlehem, PA ā€“ CryoConcepts, LP, a market leader in the development and manufacture of cryosurgical products, announced today they have received FDA clearance on two new, patent pending, cryosurgical devices for the physicianā€™s office market. CryoTouchā„¢ is a portable cryosurgical device that delivers cryogen to lesion sites and can use either applicators or cones based on the physicianā€™s preference. CryoLabĀ® is a benchtop unit that delivers cryogen for medical practices that perform a high volume of cryosurgery. The new platforms have been cleared to treat up to 23 different indications. ā€œWe are excited to get these clearances from the FDA.ā€ said Sam Niedbala, PhD and CEO of CryoConcepts, LP, ā€œCryoTouchā„¢ and CryoLabĀ® have been designed to address user needs in a product category that has not seen innovation in over two decades. Our new, patent pending, products will deliver greater efficacy and are much easier-to-use. These new products position CryoConcepts as the only company that is a one-stop source for cryosurgical products ranging from disposable devices to capital equipment.ā€ he added. The largest portion of the professional cryosurgical market consists of two basic product categories ā€“ 1. Liquid nitrogen-based delivery systems used mainly by dermatologists which require frequent refills due to evaporation and 2. Portable devices such as the HistofreezerĀ® and Verrucae FreezeĀ® that are disposable can-like devices used by Pediatricians and General Practitioners. ā€œHistofreezerĀ® and Verrucae FreezeĀ® established the disposable cryosurgical market in the early 90ā€™s,ā€ said Bill Hinchey, CMO of CryoConcepts. ā€œOur new products are easy-to-use and deliver more effective treatments while being highly efficient,ā€ he added. The company plans aggressive introductions into a variety of professional medical markets during 2019. CryoConcepts currently markets other cryo devices under the CryOmegaĀ®, CryoClearĀ®, and CooLiftingĀ® brand names.

About CryoConcepts, LP

CryoConcepts was founded by Sam Niedbala, PhD, in 2009 and is located in Bethlehem, PA. Dr. Niedbala was a co-founder and former Chief Science Officer of OraSure Technologies, Incorporated (NASDAQ: OSUR) and holds over 50 US and international patents. The management team also includes another OraSure co-founder, Bill Hinchey, who was responsible for the US launch of Histofreezer in 1991 and spent over a decade in the cryosurgical business. Mr. Hinchey serves as Chief Marketing Officer of CryoConcepts. P. Michael Formica is CryoConceptsā€™ Chief Technology Officer and served as an Executive Vice President at OraSure Technologies from 2000 to 2016. Mr. Formica was General Manager of the domestic, international, and OTC Histofreezer business during his tenure at OraSure. For more information, please visit www.CryoConcepts.com.